Quality Control Analyst I

Cambridge Isotope Laboratories, Inc. (CIL) is seeking a Quality Control Analyst I to join our team based onsite in our Andover, MA location. CIL is the global leading company in a highly technical, extremely fast-growing industry and is a critical supplier to several scientific and high technology markets. CIL's growing customer base spans academia, pharmaceutical, medical diagnostic and semiconductor industries enabling collaborations with Nobel laureates, industry-leading scientists, and chemists. CIL partners with leading instrument manufacturers as well pioneering research groups that have expertise in product development and drive market growth. CIL is a subsidiary of the Otsuka Pharmaceutical Group and has had consistent growth for over 40 years.
The Quality Control (QC) Analyst I is responsible for conducting routine analysis of materials under general supervision and in accordance with standard operating procedures (SOPs). The analyst will compile data for documentation of test procedures and prepare reports. They will also calibrate and maintain lab equipment. Some travel may be required to our Tewksbury, MA facility.
Responsibilities

• Utilize one or more of the following techniques to characterize organic and inorganic chemicals: FT-NMR, GC/MS, GC, HPLC, FT-IR and wet chemistry tests
• Follow documented procedures and document test data as required
• Any additional functions as assigned
• Write test procedures as required
• Responsible for the performing of tests and/or calibrations and evaluations or results related to GMP, ISO and non-GMP materials and products as appropriate

Requirements

• BS or MS degree in Chemistry, Chemistry Informatics or other relevant science degree, or relevant experience that will substitute for a formal degree
• Hands-on experience with Biovia LIMS/LES system preferred; Cheminformatics experience a plus
• Must be able to multi-task in a fast-paced environment and possess strong verbal and written communication skills
• One or more years of industry lab experience with benchtop chemistry experience required; QC experience preferred; GMP experience a plus
• Must be able to work effectively independently and as part of a team

Benefits
CIL offers a competitive salary and a comprehensive benefit program including generous paid time off, health insurance with no in-network deductibles, multiple Long Term Incentives and 6% matching 401K plan.
CIL is an EEO/Affirmative Action employer.
Learn more about us on our website: www.isotope.com
About us:
Cambridge Isotope Laboratories, Inc. (CIL) is the world’s leading producer of stable isotopes and stable isotope-labeled compounds. With over 700 employees and laboratories in four countries, CIL specializes in the process of labeling biochemical and organic compounds with highly enriched, stable (nonradioactive) isotopes of carbon, hydrogen, nitrogen and oxygen. Our chemists substitute common atoms (e.g., 1H, 12C, 14N, 16O) with rare, highly valued isotopes (e.g., 2H or D, 13C, 15N, 18O) so that the final product can be readily measured or traced using mass spectrometry (MS) or nuclear magnetic resonance (NMR). CIL’s products are utilized in laboratories, medical, government and academic research centers and health care facilities worldwide.
We are proud that CIL products have contributed to medical advancements in cancer research, new-drug development, environmental analysis, and medical diagnostic research. In the past decade, as the fields of proteomics and metabolomics have developed as leading techniques for determining biomarkers for disease presence, progression and the monitoring of therapeutic response, CIL has worked closely with industry leaders and researchers to provide the stable isotope-labeled tools needed for improved quantitation and qualification of complex biological systems.
After decades of research, stable isotopes have found their place in an ever expanding commercial scale applications in pharmaceuticals, semiconductors, flat panel displays as well as other high technology fields specifically with deuterium oxide (D2O) and deuterium gases. Pharmaceutical companies have begun to investigate deuteration of molecules that may provide advantages over their existing nondeuterated counterparts. In addition, increasing research into the potential medical advantages of new deuterated drugs is also occurring. In high technology, deuterated organic molecules and deuterium gas are commonly used in the manufacturing of microelectronics and OLEDs, which contribute to the increased lifetime of the devices.
Learn more about us on our website: www.isotope.com